You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in API escitalopram


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing escitalopram

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Allergan Inc LEXAPRO escitalopram 0456-2005 CELLULOSE, MICROCRYSTALLINE
Allergan Inc LEXAPRO escitalopram 0456-2005 CROSCARMELLOSE SODIUM
Allergan Inc LEXAPRO escitalopram 0456-2005 HYPROMELLOSES
Allergan Inc LEXAPRO escitalopram 0456-2005 MAGNESIUM STEARATE
Allergan Inc LEXAPRO escitalopram 0456-2005 POLYETHYLENE GLYCOL
Allergan Inc LEXAPRO escitalopram 0456-2005 SILICON DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing escitalopram

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc escitalopram 0093-5850 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc escitalopram 0093-5850 CROSCARMELLOSE SODIUM
Teva Pharmaceuticals USA Inc escitalopram 0093-5850 HYPROMELLOSE 2910
Teva Pharmaceuticals USA Inc escitalopram 0093-5850 MAGNESIUM STEARATE
Teva Pharmaceuticals USA Inc escitalopram 0093-5850 MANNITOL
Teva Pharmaceuticals USA Inc escitalopram 0093-5850 POLYETHYLENE GLYCOL 6000
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for escitalopram

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: BUTYLATED HYDROXYANISOLE

Excipient focus: BUTYLATED HYDROXYTOLUENE

escitalopram drug variants containing BUTYLATED HYDROXYTOLUENE

Company Ingredient NDC
NCS HealthCare of KY LLC dba Vangard Labs escitalopram oxalate 0615-8475
NCS HealthCare of KY LLC dba Vangard Labs escitalopram oxalate 0615-8477
QPharma Inc escitalopram oxalate 42708-077
A-S Medication Solutions escitalopram oxalate 50090-5131
A-S Medication Solutions escitalopram oxalate 50090-6023
A-S Medication Solutions escitalopram oxalate 50090-6025
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

escitalopram drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM

Company Ingredient NDC
Teva Pharmaceuticals USA Inc escitalopram 0093-5850
Allergan Inc escitalopram 0456-2005
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-7721
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8348
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8365
Major Pharmaceuticals escitalopram 0904-6426
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C RED NO. 40

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

escitalopram drug variants not containing HYDROXYPROPYL METHYLCELLULOSE

Company Ingredient NDC
Teva Pharmaceuticals USA Inc escitalopram 0093-5850
Allergan Inc escitalopram 0456-2005
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-7721
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8348
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8365
Major Pharmaceuticals escitalopram 0904-6426
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

escitalopram drug variants containing HYPROMELLOSE 2910

Company Ingredient NDC
Teva Pharmaceuticals USA Inc escitalopram 0093-5850
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-7721
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8348
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8365
Major Pharmaceuticals escitalopram 0904-6426
Torrent Pharmaceuticals Limited escitalopram 13668-135
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: HYPROMELLOSES

escitalopram drug variants not containing HYPROMELLOSES

Company Ingredient NDC
Teva Pharmaceuticals USA Inc escitalopram 0093-5850
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-7721
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8348
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8365
Major Pharmaceuticals escitalopram 0904-6426
Torrent Pharmaceuticals Limited escitalopram 13668-135
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALIC ACID

Excipient focus: MANNITOL

Excipient focus: METHYLPARABEN

Excipient focus: PEPPERMINT

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

escitalopram drug variants not containing POLYETHYLENE GLYCOL

Company Ingredient NDC
Teva Pharmaceuticals USA Inc escitalopram 0093-5850
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-7721
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8348
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8365
Major Pharmaceuticals escitalopram 0904-6426
Blenheim Pharmacal Inc escitalopram 10544-968
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: POLYETHYLENE GLYCOL 300

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: POVIDONE K12

Excipient focus: POVIDONES

Excipient focus: PROPYL GALLATE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRISODIUM CITRATE DIHYDRATE

escitalopram drug variants not containing TRISODIUM CITRATE DIHYDRATE

Company Ingredient NDC
Teva Pharmaceuticals USA Inc escitalopram 0093-5850
Allergan Inc escitalopram 0456-2005
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-7721
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8348
NCS HealthCare of KY Inc dba Vangard Labs escitalopram 0615-8365
Major Pharmaceuticals escitalopram 0904-6426
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links